200 related articles for article (PubMed ID: 31532069)
21. Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.
Frost B; Bardai FH; Feany MB
Curr Biol; 2016 Jan; 26(1):129-36. PubMed ID: 26725200
[TBL] [Abstract][Full Text] [Related]
22. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
[TBL] [Abstract][Full Text] [Related]
23. Tau Interacts with the C-Terminal Region of α-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations.
Dasari AKR; Kayed R; Wi S; Lim KH
Biochemistry; 2019 Jun; 58(25):2814-2821. PubMed ID: 31132261
[TBL] [Abstract][Full Text] [Related]
24. Regulation of tau RNA maturation by thyroid hormone is mediated by the neural RNA-binding protein musashi-1.
Cuadrado A; García-Fernández LF; Imai T; Okano H; Muñoz A
Mol Cell Neurosci; 2002 Jun; 20(2):198-210. PubMed ID: 12093154
[TBL] [Abstract][Full Text] [Related]
25. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.
Ayyadevara S; Balasubramaniam M; Parcon PA; Barger SW; Griffin WS; Alla R; Tackett AJ; Mackintosh SG; Petricoin E; Zhou W; Shmookler Reis RJ
Aging Cell; 2016 Oct; 15(5):924-39. PubMed ID: 27448508
[TBL] [Abstract][Full Text] [Related]
26. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.
Fujiwara T; Zhou J; Ye S; Zhao H
Cell Death Dis; 2016 Jul; 7(7):e2300. PubMed ID: 27441652
[TBL] [Abstract][Full Text] [Related]
27. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M
Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832
[TBL] [Abstract][Full Text] [Related]
28. Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments.
Balmik AA; Das R; Dangi A; Gorantla NV; Marelli UK; Chinnathambi S
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129467. PubMed ID: 31715192
[TBL] [Abstract][Full Text] [Related]
29. USP10 is a critical factor for Tau-positive stress granule formation in neuronal cells.
Piatnitskaia S; Takahashi M; Kitaura H; Katsuragi Y; Kakihana T; Zhang L; Kakita A; Iwakura Y; Nawa H; Miura T; Ikeuchi T; Hara T; Fujii M
Sci Rep; 2019 Jul; 9(1):10591. PubMed ID: 31332267
[TBL] [Abstract][Full Text] [Related]
30. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
31. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent changes in synaptic plasticity enhance tau oligomerization in the mouse hippocampus.
Kimura T; Suzuki M; Akagi T
Acta Neuropathol Commun; 2017 Sep; 5(1):67. PubMed ID: 28874186
[TBL] [Abstract][Full Text] [Related]
33. Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation.
Benussi L; Ghidoni R; Paterlini A; Nicosia F; Alberici AC; Signorini S; Barbiero L; Binetti G
Exp Cell Res; 2005 Aug; 308(1):78-84. PubMed ID: 15904919
[TBL] [Abstract][Full Text] [Related]
34. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
35. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression.
Hamano T; Gendron TF; Causevic E; Yen SH; Lin WL; Isidoro C; Deture M; Ko LW
Eur J Neurosci; 2008 Mar; 27(5):1119-30. PubMed ID: 18294209
[TBL] [Abstract][Full Text] [Related]
36. What is the pathological significance of tau oligomers?
Cowan CM; Quraishe S; Mudher A
Biochem Soc Trans; 2012 Aug; 40(4):693-7. PubMed ID: 22817718
[TBL] [Abstract][Full Text] [Related]
37. Phospho-Tau Impairs Nuclear-Cytoplasmic Transport.
Tripathi T; Prakash J; Shav-Tal Y
ACS Chem Neurosci; 2019 Jan; 10(1):36-38. PubMed ID: 30480430
[TBL] [Abstract][Full Text] [Related]
38. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
39. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
[TBL] [Abstract][Full Text] [Related]
40. Zinc Binding to Tau Influences Aggregation Kinetics and Oligomer Distribution.
Moreira GG; Cristóvão JS; Torres VM; Carapeto AP; Rodrigues MS; Landrieu I; Cordeiro C; Gomes CM
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
